| The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells LP Vu, BF Pickering, Y Cheng, S Zaccara, D Nguyen, G Minuesa, T Chou, ... Nature medicine 23 (11), 1369-1376, 2017 | 1028 | 2017 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 463 | 2020 |
| Cancer therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... Nature genetics 52 (11), 1219-1226, 2020 | 436 | 2020 |
| Single-cell mutation analysis of clonal evolution in myeloid malignancies LA Miles, RL Bowman, TR Merlinsky, IS Csete, AT Ooi, ... Nature 587 (7834), 477-482, 2020 | 342 | 2020 |
| Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations AM Intlekofer, AH Shih, B Wang, A Nazir, AS Rustenburg, SK Albanese, ... Nature 559 (7712), 125-129, 2018 | 262 | 2018 |
| Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease JF Emile, EL Diamond, Z Hélias-Rodzewicz, F Cohen-Aubart, F Charlotte, ... Blood, The Journal of the American Society of Hematology 124 (19), 3016-3019, 2014 | 230 | 2014 |
| Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders DM Hyman, EL Diamond, CRT Vibat, L Hassaine, JC Poole, M Patel, ... Cancer discovery 5 (1), 64-71, 2015 | 145 | 2015 |
| Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia SS Chung, E Kim, JH Park, YR Chung, P Lito, J Teruya-Feldstein, W Hu, ... Science translational medicine 6 (238), 238ra71-238ra71, 2014 | 130 | 2014 |
| Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia G Minuesa, SK Albanese, W Xie, Y Kazansky, D Worroll, A Chow, ... Nature communications 10 (1), 1-15, 2019 | 116 | 2019 |
| Clonal hematopoiesis is associated with risk of severe Covid-19 KL Bolton, Y Koh, MB Foote, H Im, J Jee, CH Sun, A Safonov, R Ptashkin, ... Nature communications 12 (1), 1-8, 2021 | 98 | 2021 |
| Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis T Gao, R Ptashkin, KL Bolton, M Sirenko, C Fong, B Spitzer, ... Nature communications 12 (1), 1-11, 2021 | 79 | 2021 |
| Impact of high-molecular-risk mutations on transplantation outcomes in patients with myelofibrosis R Tamari, F Rapaport, N Zhang, C McNamara, A Kuykendall, DA Sallman, ... Biology of Blood and Marrow Transplantation 25 (6), 1142-1151, 2019 | 56 | 2019 |
| Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma V Yellapantula, M Hultcrantz, EH Rustad, E Wasserman, D Londono, ... Blood cancer journal 9 (12), 1-9, 2019 | 51 | 2019 |
| The clinical management of clonal hematopoiesis: creation of a clonal hematopoiesis clinic KL Bolton, A Zehir, RN Ptashkin, M Patel, D Gupta, R Sidlow, ... Hematology/Oncology Clinics 34 (2), 357-367, 2020 | 47 | 2020 |
| Clonal B cells in Waldenström’s macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling KV Argyropoulos, R Vogel, C Ziegler, G Altan-Bonnet, E Velardi, ... Leukemia 30 (5), 1116-1125, 2016 | 46 | 2016 |
| PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation W Xiao, M Bharadwaj, M Levine, N Farnoud, F Pastore, BM Getta, ... Blood advances 2 (23), 3526-3539, 2018 | 45 | 2018 |
| Accelerated single cell seeding in relapsed multiple myeloma HJ Landau, V Yellapantula, BT Diamond, EH Rustad, KH Maclachlan, ... Nature communications 11 (1), 1-10, 2020 | 44 | 2020 |
| Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma EH Rustad, K Misund, E Bernard, E Coward, VD Yellapantula, ... American journal of hematology 94 (12), 1364-1373, 2019 | 25 | 2019 |
| TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes E Bernard, Y Nannya, T Yoshizato, RP Hasserjian, R Saiki, Y Shiozawa, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 23 | 2019 |
| The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis. KL Bolton, LA Moukarzel, R Ptashkin, T Gao, M Patel, N Caltabellotta, ... Journal of Clinical Oncology 38 (15_suppl), 1513-1513, 2020 | 22 | 2020 |
